Richard Ransohoff

Company: Third Rock Ventures LLC

Job title: Venture Partner

Seminars:

How Our Knowledge of Neuroinflammatory Pathophysiology Informs Understanding Potential Benefits of Cell Therapies 11:00 am

• Discussing mechanistic insights into neuroinflammatory diseases such as multiple sclerosis • Evaluating which neuroinflammatory patients are most amenable to which cell therapies based on disease understandingRead more

day: Day One Track B, AM